UPDATE: What to do now if you own, or want to buy, marijuana stocks
By Nigam Arora
Marijuana stocks are rising again, so be prepared for volatility
Marijuana stocks are hot again.
As share prices rise, the crowd gets more excited. Once again, the belief is spreading that all one has to do is to buy the hottest marijuana stocks and cash in.
This could not be further from the truth. Investors are forgetting that marijuana stocks can be very volatile. When I wrote "How to potentially become a marijuana millionaire, albeit carefully (http://www.marketwatch.com/story/how-to-potentially-become-a-marijuana-millionaire-albeit-carefully-2018-08-27)," the most important word in the headline was "carefully."
Some will make millions in marijuana stocks, but many more will lose their shirts. Let's examine this issue with the help of a chart.
Please click here (https://thearorareport.com/chart-analysis-of-marijuana-stocks-aphria-and-tilray) for a chart comparing marijuana stocks Aphria (APHA.T) and Tilray . Please note the following:
-- The chart shows when the Arora buy signal was given. Using Arora Trade Management Guidelines, the average buy price was $4.21. Hindsight shows that the buy signal was given close to the bottom. Aphria is trading at $10.67 as of this writing.
-- The reason the chart compares Aphria with Tilray is that the Arora call was to buy Aphria and sell Tilray for the medium term. Please see "Buy the previous 'don't touch' marijuana stock and sell the darling (http://www.marketwatch.com/story/buy-the-previous-dont-touch-marijuana-stock-and-sell-the-darling-2019-01-10)." At that time, Tilray was the darling and everybody was selling Aphria. My call was an unpopular contrary call.
-- The chart shows that the contrary call made a 143% performance difference in a short time.
-- Aphria is moving up on hopes of a higher buyout offer.
-- Cronos (CRON.T) is one of the strongest marijuana stocks as of this writing. Interestingly, The Arora Report made a call to buy Cronos just before it received a major investment from cigarette maker Altria (MO). This call produced large gains in a very short time. The call to buy was made at $9.41. Cronos is trading at $22.41 as of this writing.
-- In addition to Cronos and Aphria, there are several marijuana stocks in our diversified marijuana portfolio. They include Canopy Growth (WEED.T) and New Age Beverages (NBEV). Please see "If you buy only one marijuana stock, this should be it (http://www.marketwatch.com/story/if-you-buy-only-one-marijuana-stock-this-should-be-it-2018-10-05)."
-- Marijuana stocks have once again become uncorrelated to the Dow Jones Industrial Average , S&P 500 ETF (SPY) and Nasdaq 100 ETF (QQQ).
Ask Arora: Nigam Arora answers your questions about investing in stocks, ETFs, bonds, gold and silver, oil and currencies. Have a question? Send it to Nigam Arora (mailto:email@example.com).
The real reason behind the runup
The real reason behind the recent runup in marijuana stocks is a short squeeze, according to the algorithms at The Arora Report. In a short squeeze, investors who previously sold short are either forced to buy to cover their shorts or feel compelled to buy to cover at higher and higher prices. Such buying is artificial buying and not real buying based on fundamentals. In the stock market, there are not many things we know with certainty. However, we know with certainty that short squeezes eventually end. When they end, then the stocks fall.
Segmented money flows give you the biggest edge. They help you not only make money but also stop you from becoming bag holders at the hands of insiders as well as pumpers-and-dumpers.
As of this writing, money flows show that the momo crowd is aggressively buying marijuana stocks. However, the smart money is not buying, and even selling, on "up" spikes. To learn about segmented money flows, please see "How 'peak good news' for marijuana stocks may undermine investors (http://www.marketwatch.com/story/how-peak-good-news-for-marijuana-stocks-may-undermine-investors-2018-11-08)."
Please click here (https://thearorareport.com/chart-money-flows-cannabis-stocks-20192801) for a previously published chart of segmented money flows on 15 marijuana stocks including Aurora Cannabis (ACB.T), Constellation Brands (STZ) and marijuana ETF (MJ).
What to do now
Those who are aggressive and holding marijuana stocks may consider continuing to hold core positions but take partial profits on the rest.
Those who are holding positions larger than the core positions or trade-around positions may consider taking partial profits.
Those who are growth-oriented and holding marijuana stocks may consider slightly trimming core positions at the edges by taking partial profits.
Those not in marijuana stocks may consider waiting patiently for signals to buy select marijuana stocks.
Arora's 14th Law is directly applicable in this situation: To be successful at investing and trading, become a master of position sizing. Position sizing is critical to investing in marijuana stocks. In addition, using techniques such as trade-around positions is especially important.
Please also read:
To invest successfully in marijuana stocks, avoid this one thing (http://www.marketwatch.com/story/to-invest-successfully-in-marijuana-stocks-add-this-pointer-to-your-list-of-things-to-do-2018-10-09)
How to survive marijuana stocks' rollercoaster ride (http://www.marketwatch.com/story/how-to-survive-marijuana-stocks-rollercoaster-ride-2018-09-24)
Seven reasons Big Tobacco is likely to make a move on the marijuana industry (http://www.marketwatch.com/story/seven-reasons-why-big-tobacco-is-likely-to-make-a-move-on-the-marijuana-industry-2018-09-10)
Tilray is the poster boy of short-squeeze stock candidates -- here's how to find others (http://www.marketwatch.com/story/tilray-is-the-poster-boy-of-short-squeeze-stock-candidates-heres-how-to-find-others-2018-09-19)
Marijuana beverages are the new thing, but investors should only take sips (http://www.marketwatch.com/story/marijuana-beverages-are-the-new-thing-but-investors-should-only-take-sips-2018-10-02)
Disclosure: Subscribers to The Arora Report (http://thearorareport.com/) may have positions in the securities mentioned in this article or may take positions at any time. Nigam Arora is an investor, engineer and nuclear physicist by background who has founded two Inc. 500 fastest-growing companies. He is the founder of The Arora Report, which publishes four newsletters. Nigam can be reached at Nigam@TheAroraReport.com (mailto:Nigam@TheAroraReport.com).
-Nigam Arora; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
02-06-19 1424ETCopyright (c) 2019 Dow Jones & Company, Inc.